During their development, T cells are rescued from apoptotic cell death to follow distinct lineage fates. Recent data concerned with the role of the Notch transmembrane receptor in these events are interpreted to show that Notch promotes survival, but contrary to earlier reports has no function in lineage commitment.
As lymphocytes develop from pluripotent stem cells, they rearrange their antigen receptor genes, which are present in pieces in the germ-line genome. These gene segments must be rearranged to produce functional receptors in order for a lymphocyte to survive and mature. Indeed several 'checkpoints' have been identified at which developing T and B lymphocytes have to make a particular type of receptor in order to proceed to the next developmental stage. In the case of T cells, not only whether they will survive but also which particular lineage they will follow is determined at these checkpoints [1] .
The molecular mechanisms underlying these processes are not known, and may depend entirely or in part on the particular receptor expressed. T-cell development can also be influenced by the evolutionarily conserved transmembrane receptor Notch. The indications of this [2, 3] suggested that Notch affects T-cell lineage commitment, analogous to its impact on lineage decisions in the fruitfly Drosophila [4] . But a new paper [5] claims that Notch has an anti-apoptotic activity in T-cell development, rather than a function in lineage commitment.
There are two checkpoints during T-cell development at which cells are rescued from cell death and enter distinct lineages ( Figure 1 ). The first occurs as T-cell receptor β, γ and δ genes rearrange. If a cell makes productive γ and δ rearrangements, it can express the heterodimeric γδ receptor; if it makes a productive β rearrangement, it can make the pre-T-cell receptor that consists of the β chain and the pre-T-cell receptor α protein, which is encoded by a nonrearranging gene [6] . Cells that can produce neither the γδ receptor nor the pre-T-cell receptor will die at this stage of development. Cells that express the γδ or the pre-T-cell receptor can enter the γδ or αβ T-cell lineage. These lineages have distinct properties, which means they can be defined independently of the particular antigen receptor expressed, and it is not yet clear to what extent expression of either the γδ or pre-T-cell receptor determines lineage commitment, or how this is effected at a molecular level.
Cells that enter the αβ lineage pass through a second checkpoint as they rearrange and express their α chain genes. In αβ lineage cells, the pre-T-cell receptor rescues cells from death, terminates further rearrangement at the β, γ and δ loci and induces a strong wave of proliferation, followed eventually by rearrangements at the α chain locus and expression of CD4 and CD8 'coreceptors' [7] . These so-called CD4 + CD8 + cells, some of which express an αβ T-cell receptor, cease dividing and are programmed to die after three to four days unless their antigen receptor and CD4 or CD8 coreceptor together bind to thymic major histocompatibility complex (MHC) molecules. While the αβ receptor binds to peptides presented by either class I or class II MHC molecules, CD4 binds only to class II and CD8 only to class I MHC molecules. Appropriate binding of the αβ receptor and coreceptors to the same MHC molecule results in rescue of the cells from apoptotic cell death, and the rescued cells differentiate into either CD4 + CD8 -cells or CD4 -CD8 + cells (Figure 1 ), depending on whether their αβ T-cell receptor is specific for class II or class I MHC presented peptides [8] . The CD4 and the CD8 lineages of mature T cells have distinct properties, and again the molecular mechanisms of lineage commitment may depend entirely or in part on the specificity of the receptor.
The first reports analysing the impact of Notch on T-cell development postulated a role for Notch in lineage decision at both checkpoints [2, 3] . These experiments built upon the previous analysis of Notch function in the fruitfly Drosophila, where Notch is believed to be involved in lineage decisions of ectodermal cells [4] . Neighbouring cells with slightly different levels of Notch and Notch ligands on the cell surface are thought to influence each other by lateral signalling, such that the difference becomes exaggerated and one cell expresses high levels of Notch while the other cell does not. This can result in distinct lineage commitment in that cells expressing high levels of Notch assume one developmental fate, while the cells expressing low levels assume another, as seen in the experiments on Drosophila ectodermal cells. In mosaic fruitflies containing both Notch +/+ and Notch +/-ectodermal cells, the latter regularly assumed the neural fate only, while in Notch +/-fruitflies such cells contributed to both epidermis and neurons [8] . At a molecular level, it is known that the activation of Notch by various ligands results in cleavage of the receptor such that the intracellular domain -known as Notch IC -can act in the nucleus and initiate signalling. Furthermore, Notch signalling can enhance Notch expression, leading to positive feedback [9] .
The experiments looking at the effect of Notch activity on the first checkpoint in T-cell development used mice with a chimaeric haemopoietic system populated by a mixture of Notch +/-and Notch +/+ cells. An effect on lineage commitment to either the γδ or αβ lineage was postulated, because in these chimaeras the Notch +/-T cell precursors appeared to contribute less to the αβ lineage than Notch +/+ precursors. Also, an activated Notch transgene was shown to increase significantly the number of αβ lineage CD4 + CD8 + cells in mice that were deficient in the T-cell receptor β locus and so could not make either the pre-Tcell receptor or the αβ receptor. These experiments could be interpreted as indicating that cells expressing high levels of Notch assume the αβ lineage fate by lateral signalling mechanisms similar to those causing ectodermal cells to assume an epidermal fate. The observed changes caused by active Notch were, however, not independent of receptor gene rearrangement, as Notch transgenic, rearrangement-deficient Rag -/-mice did not show any accumulation of αβ lineage cells [3] .
At the second checkpoint in T-cell development, active Notch caused an accumulation of CD4 -CD8 + T cells, even in mice deficient in MHC class I molecules, but not in MHC-negative mice. This was interpreted to show that at this point in development the CD8 lineage, which normally requires ligation of the receptor by class I MHC molecules, was favoured by cells expressing active Notch. Unlike normal CD8 cells, however, the cells rescued by Notch were short-lived and could not be detected in secondary lymphoid tissue [2] .
The interpretation of these results has now been challenged by Deftos et al. [5] . They observed that the intracellular form of Notch, Notch IC, mediates resistance to corticosteroid-induced apoptosis, to which CD4 + CD8 + thymocytes are particularly susceptible. Resistance to apoptosis requires activation of the transcription factor RBP/Su(H). Deftos et al. [5] also describe a Notch ICdependent increase in Notch expression that apparently is dependent on activation of the Deltex gene as well as upregulation of the anti-apoptotic gene bcl-2 in an AKR thymoma. This cell line resembles CD4 + CD8 + thymocytes in its expression of the CD4 and CD8 coreceptors, and in normally being susceptible to corticosteroid-induced apoptosis. Interestingly, CD4 + CD8 + thymocytes undergoing rescue from apoptosis through binding of their αβ receptor to MHC molecules resemble Notch IC-expressing AKR cells in becoming resistant to apoptosis and upregulating bcl-2 expression. Further parallels are seen in that surface levels of the αβ receptor on the AKR thymoma increased in response to Notch IC, mimicking the increase in cell surface αβ receptor expression when CD4 + CD8 + thymocytes bind an appropriate peptide-MHC ligand and are rescued from cell death.
Because of these interesting parallels, Deftos et al. [5] searched for signs of Notch and Deltex activity in various Checkpoints in T-cell development. At the first checkpoint, T cells that have undergone receptor gene rearrangement are rescued from programmed cell death by production of either a γδ receptor or the pre-T-cell receptor. At the second checkpoint, cells on the αβ lineage are rescued from programmed cell death by binding of their αβ T-cell receptor to thymic MHC molecules. Commitment to either the αβ or γδ lineage takes place at the first checkpoint, and commitment to either the CD4 + CD8 -or CD4 -CD8 + lineage takes place at the second checkpoint. [5] conclude that Notch is involved in the generation of not only CD4 -CD8 + but also CD4 + CD8 -thymocytes ( Figure 2 ).
There is relatively little to be concluded from these observations on the first checkpoint in T-cell development, as CD4 -CD8 -thymocytes consist of distinct subsets of cells that may or may not have passed through this checkpoint and they have yet to be analysed separately for Notch and Deltex expression. With regard to the second checkpoint, Deftos et al. [5] note that a class I MHC-independent generation of short-lived CD4 -CD8 + thymocytes was not only observed in Notch transgenic mice [2] but also in bcl-2 transgenic mice [10] , suggesting that enhanced cell survival could be solely responsible for the generation of these peculiar CD4 -CD8 + cells.
On the basis of these observations, Deftos et al. [5] develop a scenario, which could account for some of the earlier findings that suggested a possible role for Notch in lineage commitment at the second checkpoint in T-cell development. They argue that the quality of the interaction of the T-cell receptor with MHC molecules may be responsible for lineage fate decision, in that the CD4 + CD8 -lineage might require a stronger receptor signal than the CD4 -CD8 + lineage, whereas Notch is postulated to be involved only with survival. According to this view, the better survival of CD4 + CD8 + thymocytes in Notch transgenic mice somehow facilitates the relatively weak signalling required for CD4 -CD8 + cell development, but has little influence on the generation of CD4 + CD8 -cells which requires stronger signals. While these notions clearly belong in the category of immuno-speculation, it may be of interest to test them with further experiments. 
